RAU’s Respiratory Care Pharmacology
v v v
9TH EDITIONv
BY GARDENHIRE
v
TEST BANK v
,Description
Test Bank for Rau’s Respiratory Care Pharmacology 9th Edition Gardenhire
v v v v v v v v v
Test Bank for Rau’s Respiratory Care Pharmacology, 9th Edition, Gardenhire, ISBN-10:
v v v v v v v v v v
0323299687, ISBN-13: 9780323299688
v v v
Table of Contents
v v
Unit I: Basic Concepts and Principles in Pharmacology
v v v v v v v
1. Introduction to Respiratory Care Pharmacology
v v v v v
2. Principles of Drug Action
v v v v
3. Administration of Aerosolized Agents
v v v v
4. Calculating Drug Doses
v v v
5. The Central and Peripheral Nervous Systems
v v v v v v
Unit II: Drugs Used to Treat the Respiratory System
v v v v v v v v
6. Adrenergic (Sympathomimetic) Bronchodilators
v v v
7. Anticholinergic (Parasympatholytic) Bronchodilators
v v v
8. Xanthines
v
9. Mucus-Controlling Drug Therapy
v v v
10. Surfactant Agents
v v
11. Corticosteriods in Respiratory Care
v v v v
12. Nonsteroidal Antiasthma Agents
v v v
13. Aerosolized Antiinfective Agents
v v v
14. Antimicrobial Agents
v v
15. Cold and Cough Agents
v v v v
16. Selected Agents of Pulmonary Value
v v v v v
17. Neonatal and Pediatric Aerosolized Drug Therapy
v v v v v v
Unit III: Critical Care, Cardiovascular, and Polysomnography Agents
v v v v v v v
18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
v v v v v v
19. Diuretic Agents
v v
20. Drugs Affecting the Central Nervous System
v v v v v v
21. Vasopressors, Inotropes, and Antiarrythmic Agents
v v v v v
22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
v v v v v v
23. Sleep and Sleep Pharmacology
v v v v
,Chapter 01: Introduction to Respiratory Care Pharmacology
v v v v v v
v Gardenhire: Rau’s Respiratory Care Pharmacology, 9th Edition
v v v v v v
MULTIPLE CHOICE v
1. What is the name of the receptor sites that are located in the peripheral vasculature, the heart, bronchial
v v v v v v v v v v v v v v v v v
muscle, and bronchial blood vessels?
v v v v v
a. Beta 2 receptors v v c. Alpha receptors v
b. Gamma receptors v d. Beta 1 receptors v v v v
ANS: C v
Alpha receptors are located in the peripheral vasculature, the heart, bronchial muscle, and bronchial
v v v v v v v v v v v v v
blood vessels.
v v
PTS: 1 v
2. Which receptor site results in tachycardia, an increased potential for arrhythmias, and an increased
v v v v v v v v v v v v v
cardiac output?
v v
a. Beta 1 receptor v v c. Alpha receptor v
b. Beta 2 receptor v v d. Delta receptor v v
ANS: A v
Stimulation of the beta-1 receptors results in tachycardia, an increased potential for arrhythmias, and
v v v v v v v v v v v v v
an increased cardiac output. In administering drugs to the pulmonary system, stimulation of the beta-1
v v v v v v v v v v v v v v v
sites is not desired. However, most respiratory pharmacologic agents have some beta-1 stimulatory
v v v v v v v v v v v v v
effect.
v
PTS: 1 v
3. Stimulation of the beta 2 receptors causes v v v v v v v
a. peripheral vasoconstriction and mild bronchoconstriction in the lungs.
v v v v v v v
b. tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
v v v v v v v v v v
c. bronchodilation.
d. peripheral vasodilation, bradycardia, and decreased cardiac output.
v v v v v v
ANS: C v
Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
v v v v v v v v v
PTS: 1 v
4. Acetylcholine stimulates v v
a. the Vagus nerve.
v v
b. the adrenergic receptors.
v v
c. the sympathetic nervous system.
v v v
d. the cholinergic receptors.
v v
ANS: D v
Acetylcholine stimulates the cholinergic receptors. v v v v
PTS: 1 v
5. What immunoglobulin antibody sensitizes the mast cell?
v v v v v v
a. Leukotrienes c. Histamine
, b. IgE d. Prostaglandins
v
ANS: B v
The IgE (reagin) antibodies sensitize the mast cell. Repeated exposure to the antigen causes the
v v v v v v v v v v v v v v
degranulation of the mast cell.
v v v v v
PTS: 1 v
6. Which of the following is caused by histamine release from the mast cells?
v v v v v v v v v v v v
I. Bronchodilation
II. Increased bronchial gland secretion v v v
III. Increased amount of mucus present in the airways v v v v v v v
a. I and II onlyv v c. III only
v v
b. II and III only v v d. I, II, III
v v v v v
ANS: B v
Histamine is also a potent bronchoconstrictor. In addition to its bronchoconstrictive activity, histamine
v v v v v v v v v v v v
II) increases bronchial gland secretion, causing III) an increase in the amount of mucus present
v v v v v v v v v v v v v v
in the airways. Histamine may also have an effect on vascular permeability similar to the effect
v v v v v v v v v v v v v v v v
of- SRS-A.
v v
PTS: 1 v
7. A sympathomimetic drug would cause
v v v v v
a. bronchodilation. c. Histamine release. v
b. bronchoconstriction. d. Vagus nerve stimulation.
v v v
ANS: A v
A sympathomimetic drug would cause bronchodilation. Sympathomimetic agents are the drugs most
v v v v v v v v v v v
commonly used to reverse bronchospasm.
v v v v v
PTS: 1 v
8. Stimulation of the sympathetic nervous system causesv v v v v v v
a. vascular permeability. c. bronchodilation.
v
b. decreased blood pressure. d. bronchoconstriction.
v v v
ANS: C v
Sympathetic nervous system stimulation causes bronchodilation.
v v v v v
PTS: 1 v
9. Which of the following would NOT cause a bronchospasm or bronchoconstriction?
v v v v v v v v v v
a. Leukotrienes c. Histamine
b. Beta 1 receptors v d. Prostaglandins
v v
ANS: B v
Beta-1 receptors would not cause a bronchospasm or bronchoconstriction. Leukotrienes are one of
v v v v v v v v v v v v
many chemical mediators released by the mast cells. Leukotrienes cause a direct, strong
v v v v v v v v v v v v v
bronchoconstriction. Histamine is also a potent bronchoconstrictor. Prostaglandins cause a strong
v v v v v v v v v v v
bronchospasm, especially in asthmatic patients.
v v v v v
PTS: 1 v